Home>Clinical research>Clinical trials by disease>TES for the Treatment of Retinitis Pigmentosa (RP)
How to use the speech recognition tool?
TESOLAUK - NCT01847365
TES for the Treatment of Retinitis Pigmentosa (RP)
TES for the Treatment of Retinitis Pigmentosa (RP).
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2013-04-01
- Closing Date: 2015-02-01
Criteria
Children: No
Adults: Yes
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)